Zoetis (NYSE:ZTS) Given New $180.00 Price Target at Stifel Nicolaus

Zoetis (NYSE:ZTS) had its price objective decreased by analysts at Stifel Nicolaus from $210.00 to $180.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 9.13% from the company’s previous close.

Other research analysts have also issued research reports about the stock. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price for the company. JPMorgan Chase & Co. increased their target price on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. UBS Group initiated coverage on Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $211.89.

Zoetis Stock Down 0.6 %

NYSE:ZTS traded down $0.96 during mid-day trading on Tuesday, reaching $164.94. The stock had a trading volume of 529,098 shares, compared to its average volume of 1,905,701. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The stock has a market cap of $74.42 billion, a P/E ratio of 31.00, a PEG ratio of 2.91 and a beta of 0.89. The business’s 50 day moving average is $173.07 and its 200 day moving average is $180.47. Zoetis has a fifty-two week low of $144.80 and a fifty-two week high of $200.53.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the previous year, the firm earned $1.36 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, sell-side analysts predict that Zoetis will post 5.9 earnings per share for the current year.

Institutional Trading of Zoetis

A number of large investors have recently bought and sold shares of ZTS. Pensionfund Sabic raised its stake in shares of Zoetis by 55.6% in the fourth quarter. Pensionfund Sabic now owns 11,200 shares of the company’s stock valued at $1,825,000 after acquiring an additional 4,000 shares during the last quarter. JPMorgan Chase & Co. raised its position in Zoetis by 10.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company’s stock valued at $569,834,000 after purchasing an additional 279,092 shares during the last quarter. Simplify Asset Management Inc. acquired a new position in Zoetis in the third quarter worth $11,684,000. B&L Asset Management LLC bought a new stake in shares of Zoetis during the third quarter worth $563,000. Finally, Geode Capital Management LLC increased its stake in shares of Zoetis by 1.8% in the third quarter. Geode Capital Management LLC now owns 10,427,760 shares of the company’s stock valued at $2,030,813,000 after buying an additional 185,364 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.